PHAXIAM Therapeutics S.A. (EPA:PHXM)

PHAXIAM Therapeutics Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	10.47	38.79	33.7	44.45	73.17
Short-Term Investments	-	-	-	-	0.01
Cash & Short-Term Investments	10.47	38.79	33.7	44.45	73.19
Cash Growth	-73.00%	15.10%	-24.18%	-39.27%	-45.53%
Accounts Receivable	0.1	0.08	0.01	0	0.04
Other Receivables	4.76	2.46	4.22	4.33	5.79
Receivables	4.86	2.53	4.23	4.33	5.82
Inventory	-	-	-	-	0.36
Prepaid Expenses	0.67	0.81	1.26	0.79	0.89
Other Current Assets	0.21	0.51	0.86	0.06	1.32
Total Current Assets	16.22	42.63	40.05	49.63	81.58
Property, Plant & Equipment	3.9	2.98	25.83	29.09	35.64
Long-Term Investments	-	0	0.06	0.02	0.02
Goodwill	9.62	-	-	-	-
Other Intangible Assets	21.36	0.01	0.02	0.59	0.6
Other Long-Term Assets	0.21	0.19	0.82	1.07	0.7
Total Assets	51.31	45.81	66.77	80.4	118.55
Accounts Payable	3.68	1.56	2.49	4.71	5.07
Accrued Expenses	3.43	3.55	11.67	20.35	12.33
Short-Term Debt	-	-	-	2.17	0.04
Current Portion of Long-Term Debt	3.17	2.57	0.16	0.1	0.06
Current Portion of Leases	0.72	0.78	1.82	1.61	1.43
Current Income Taxes Payable	3.45	2.8	3.72	-	-
Current Unearned Revenue	-	0.05	0.09	0.15	0.06
Other Current Liabilities	0.82	0.37	0.06	0.27	0.89
Total Current Liabilities	15.26	11.68	20.01	29.35	19.88
Long-Term Debt	7.03	7.55	15.23	14.38	1.32
Long-Term Leases	2.35	2.68	8.16	9.2	11.28
Other Long-Term Liabilities	0.68	0.1	-	0.29	-
Total Liabilities	25.7	22.32	43.92	53.86	32.99
Common Stock	6.08	3.1	3.1	2.01	1.79
Additional Paid-In Capital	49.67	48.98	97.62	120.71	281.69
Retained Earnings	-23.49	-0.23	-53.8	-73.3	-62.66
Comprehensive Income & Other	-6.65	-28.36	-24.08	-22.87	-135.26
Shareholders' Equity	25.61	23.49	22.85	26.54	85.56
Total Liabilities & Equity	51.31	45.81	66.77	80.4	118.55
Total Debt	13.27	13.57	25.38	27.45	14.12
Net Cash (Debt)	-2.79	25.22	8.32	17	59.06
Net Cash Growth	-	203.00%	-51.03%	-71.22%	-55.37%
Net Cash Per Share	-0.59	8.13	3.51	9.24	32.93
Filing Date Shares Outstanding	6.07	3.1	3.1	2.01	1.79
Total Common Shares Outstanding	6.07	3.1	3.1	2.01	1.79
Working Capital	0.96	30.96	20.04	20.29	61.7
Book Value Per Share	4.22	7.57	7.37	13.23	47.70
Tangible Book Value	-5.37	23.48	22.83	25.95	84.96
Tangible Book Value Per Share	-0.88	7.57	7.36	12.94	47.36
Machinery	6.83	6.78	29.12	27.69	28.36
Construction In Progress	0.67	-	0.11	0.08	1.08

Updated Sep 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.